Try our beta test site

Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David Asmuth, MD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT01869634
First received: June 1, 2013
Last updated: January 12, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2016
  Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)